Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Effects of Abaloparatide on Bone Formation in Postmenopausal Osteoporosis
NCT03710889Phase 3Completed
- Sponsor
- Radius Health Inc
- Start
- Sep 2018
- Primary completion
- Jul 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of abaloparatide in postmenopausal osteoporosis, sponsored by Radius Health Inc. Started Sep 2018; status: completed.
02
Drugs
abaloparatide
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT03710889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03710889.